What swissdamed changes organisationally
Actor and product registration are separate responsibilities. Manufacturers, authorised representatives and other affected economic operators need clear ownership, while product data, UDI references and market information must be prepared consistently. The portal is therefore the final step in an internal data and approval process.
Which data needs to come together
A dependable preparation covers unambiguous product names, variants, UDI data, manufacturer and actor references, and controlled evidence. Broad portfolios are particularly exposed when item numbers, regulatory identifiers and documents are maintained in disconnected systems.
A practical registration process
Start with data ownership and quality rules, continue through internal review and approval, and submit only controlled records. Status, validation feedback and corrections should flow back into the product record so registration does not become a one-off upload exercise.
How RIM supports preparation
Regulatory Information Management connects product objects, dossiers, roles, documents, tasks and submission status. This allows swissdamed and EUDAMED to remain separate authority processes while reusing the same governed data foundation.
Frequently asked questions about swissdamed
When did product registration become mandatory?
Product registration in swissdamed has been mandatory since 1 July 2026; affected products already on the market have a transition period until 31 December 2026. Specific cases can require immediate registration.
Are EUDAMED records transferred automatically?
No. Swissmedic states that there is no direct interface for automatic synchronisation. Prepared data can largely be reused, but it must be actively provided to swissdamed.
Is the work finished after initial registration?
No. Product, actor and status changes need controlled maintenance. A defined ownership and approval process therefore remains necessary.
Professional orientation only, not legal advice. Current Swissmedic requirements remain authoritative.